You are a helpful, respectful, and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information.
What is Bad prognosis in AML is indicated by aEUR' and explain in detail?
Monosomy Prognostic factors in AML Favourable prognostic factors Unourable prognostic factors Miscellaneous prognostic factors * Age < 40 yrs * del (7q) * In recent years, with availability * AML without antecedent MDS/ MPD * dui (5q) of markers on bone marrow * Blast cells with Auer rods * 11q23 - MLL +ve trephine sections, it has been * TLC < (25 x 109/L) * 3q21 possible to study antiogenesis, * t (15;17) in AML - M3- PMURARA +ve ' Expression of MDR-1 gene (Multidrug proliferative index, apoptosis and * t (8;21) in AML-M, * Inv (16) in AML- M4Eo resistance gene) * 3q26 other parameters * FAB subtype - AML- M2, M3, M4 *Complex karyotypes * High WBC count > 100 x 109/L * AML with preceeding MDS/ PMD * Extremes of age <2 years and > 55 years FLT-3 mutation * -7/7q * Extramedullary disease in AML- M5 * Presence of CNS involvement * FAB subtype AML -MO, M6, M7 -- * t (8 ; 21)Q in AML - M2 Good prognosis * Inv (16) in AML- M4 E,, * t (15 ; 17)Q in AML - M3 - PML /RAFA +ve Moderately ourable outome * No cytogenetic abnormality Q * del (7q) * Monosomy 5 or 7 * del (5q) * inv (3) (q 21. q 26) * 11(123 - MLL +ve * t (3;3) Poor prognosis * 3q21 * t (6:11) * Expression of MDR-1 gene * t (10:11) * 3q26 * t (9;22) Genetic abnormalities in normal cytogenetic AML Name Prognosis Prevalence Expression NPM-1 (nuclephosmin) Favourable 50-60% Mutation FLT3-ITD The Ems - like tyrosine kinase 3 Gene Unourable 3040% Mutation FLT3 -Asp835 Unclear 5 - 10% Mutation BAALC (Brain and acute leukemia cytoplasmic) Unourable 65.7% Over expression MNI (Meningioma I) Unourable 50% Over expression MLI -PTD (Mixed lineage leukemia) Unourable 7.7% Mutation / over expression CEBPa (CCAT/Enhancer binding protein alpha gene) Favour able 15 - 20% Mutation ERG-I (The E1S-related gene Unoruable 25% Over expression AF-lq expression Unourable 75% Over expression Nuleophosmin (NPM1) mutations The most common molecular abnormality present in -50% of AML's with normal karyotype. nK- AML constitutes -45% of AML's and conveys an "intermediate" (but heterogenous) prognosis. Exon 12 NEM] mutations (always 4bp inseions) disrupt a key regulatory region. "AML with mutated NPM (nusleophosmin) has a ourable prognosis". Loss of X.Y chromosome There is a correlation between t (8;21) and involvement of sex chromosomes (X, Y chromosomes) - Involvement of sex chromosome occur in cases with t (8;21) that may be either in the .form of loss of X chromosome or duplication of Y chromosome. - Loss of the Y chromosome or loss of the X chromosome is associated with t (8;21) in 80% to 90% cases. - But the significance of these abnormalities on prognosis is not clear. Most probably they have ourable prognosis just as t(8;21).